FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/05/087275 [Registered on: 21/05/2025] Trial Registered Prospectively
Last Modified On: 16/05/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Other 
Public Title of Study   Study to assess efficacy of blockbuster LMA for ventilation and intubation 
Scientific Title of Study   A Study To Assess Efficacy Of Blockbuster LMA For Ventilation And Intubation 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Shahil Ahmed 
Designation  Junior Resident 2 
Affiliation  Government Medical College,Haldwani 
Address  Department of Anaesthesiology,critical care,pain and palliative medicine,2nd floor,Susheela Tiwari hospital,Haldwani,

Nainital
UTTARANCHAL
263139
India 
Phone  8851246362  
Fax    
Email  asahil786326@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr. Geeta Bhandari 
Designation  Professor and HOD,department of anesthesiology 
Affiliation  Government Medical College,Haldwani 
Address  Department of Anaesthesiology,critical care,pain and palliative medicine,2nd floor,Susheela Tiwari hospital,Haldwani,

Nainital
UTTARANCHAL
263139
India 
Phone  8650655556  
Fax    
Email  bhandari_geetantl@rediffmail.com  
 
Details of Contact Person
Public Query
 
Name  Shahil Ahmed 
Designation  Junior Resident 2 
Affiliation  Government Medical College,Haldwani 
Address  Department of Anaesthesiology,critical care,pain and palliative medicine,2nd floor,Susheela Tiwari hospital,Haldwani,

Nainital
UTTARANCHAL
263139
India 
Phone  8851246362  
Fax    
Email  asahil786326@gmail.com  
 
Source of Monetary or Material Support  
Department of anaesthesiology,critical care,pain and palliative medicine,Susheela tiwari hospital,Haldwani,Uttarakhand-263139 
 
Primary Sponsor  
Name  Dr Shahil ahmed 
Address  Department of anaesthesiology,critical care,pain and palliative medicine,Susheela tiwari hospital,Haldwani,Uttarakhand-263139 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Shahil Ahmed  Susheela tiwari hospital  Department of Anaesthesiology,critical care,pain and palliative medicine,2nd floor,Susheela Tiwari hospital,Haldwani,
Nainital
UTTARANCHAL 
08851246362

asahil786326@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IEC,GMC,HALDWANI  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K00-K95||Diseases of the digestive system, (2) ICD-10 Condition: H60-H95||Diseases of the ear and mastoid process, (3) ICD-10 Condition: H00-H59||Diseases of the eye and adnexa, (4) ICD-10 Condition: N00-N99||Diseases of the genitourinary system, (5) ICD-10 Condition: M00-M99||Diseases of the musculoskeletal system and connective tissue,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Blockbuster LMA  The study of 200 patients.Group B used Blockbuster as ventilatory device in 1-2 minutes 
Comparator Agent  Blockbuster LMA  The study of 200 patients.Group B used Blockbuster as ventilatory device within 1 minutes 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1. Patients giving informed written consent for participation in the study.
2. Patients posted for surgery under general anesthesia.
3. Age of the patient between 18-65 of either sex.
4. Patients belonging to American Society of Anaesthesiology class I and II.
5. Patients belonging to Modified Mallampatti Score of class I and II.
 
 
ExclusionCriteria 
Details   
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
•To study the first attempt successful intubation done using blockbuster LMAs and NG insertion.
 
24hrs 
 
Secondary Outcome  
Outcome  TimePoints 
•The time of LMA insertion & LMA removal.

•Any intra-op & post-op complications occurring using LMAs.


•To observe hemodynamic changes during insertion of LMAs
 
2hrs,8hs,24 hrs 
 
Target Sample Size   Total Sample Size="200"
Sample Size from India="200" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   29/05/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The present study is a Prospective, Randomized and Comparative study done after approval of Institutional Ethics Committee in patients satisfying all inclusion and exclusion Criteria planned for short surgeries under GA. Material used were Blockbuster LMA, Anaesthesia workstation, suction apparatus, Laryngoscope and ET Tubes of various sizes. After careful preoperative assessment of all patients’ standard monitors including NIBP, ECG, and pulse oximeter will be attached to the patient. The study population is divided into single group of 200 patients. Group B used Blockbuster as ventilatory device. In the operating room, an 18G IV cannula is inserted into both hands. Ringer lactate solution is infused at 10ml/kg. Patients receive 100% oxygen for 3 minutes, followed by premedication. Standard monitoring is connected. Anesthesia is induced with propofol and vecuronium and maintained with oxygen, nitrous oxide, and sevoflurane after introducing allocated SAD. parameters like-successful insertion time, number of attempts of insertion, oropharyngeal leak pressure and vitals like- pulse rate, blood pressure, SpO2 , EtCO2 and ventilator parameters will be noted before induction of anesthesia, throughout surgery and immediately after removal of the device after completion of surgery 
Close